Norwich, CT, United States of America

Deane M Nason, Ii

This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Deane M Nason, Ii. Retrieved from https://idiyas.com/inventor/deane-m-nason-ii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Deane M Nason, II: Innovator in Calcium Channel Blocking Polypeptides

Introduction

Deane M Nason, II is a notable inventor based in Norwich, CT (US). He has made significant contributions to the field of biochemistry, particularly in the development of calcium channel blocking polypeptides derived from the species Filistata hibernalis. His innovative work has led to advancements in medical science and therapeutic applications.

Latest Patents

Deane holds 1 patent for his invention titled "Calcium channel blocking polypeptides from Filistata hibernalis." This patent showcases his expertise in biochemistry and his commitment to advancing medical research.

Career Highlights

Currently, Deane is employed at Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to collaborate with other experts in the field and contribute to groundbreaking research and development projects.

Collaborations

Throughout his career, Deane has worked alongside talented colleagues, including Robert T Ronau and Robert A Volkmann. These collaborations have fostered an environment of innovation and creativity, leading to significant advancements in their respective fields.

Conclusion

Deane M Nason, II is a distinguished inventor whose work in calcium channel blocking polypeptides has made a lasting impact on medical science. His contributions continue to inspire future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…